Healthcare / Health Information ServicesShenzhen
$25.49
+0.64 (+2.50%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 22%
FCF escenarios
weak_data · normalized FCF $-29.7M · quality 61.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
18/100
F
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$2.7B
P/E
N/A
•EV/EBITDA
N/A
•ROE
-1.4%
↓Gross Margin
36.2%
↓Debt/Equity
0.01
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-10.4%
FCF CAGR
—
FCF margin
-11.7%
FCF / Net income
2.01x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $254.1M · net income $-14.8M · FCF $-29.7M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $254.1M | $254.1M | $217.9M | $351.3M | $352.6M |
| Net Income | $-14.8M | $-14.8M | $-26.5M | $45.5M | $79.1M |
| EBITDA | $-5.6M | $-5.6M | $-18.9M | $61.6M | $98.7M |
| EPS | -0.14 | -0.14 | -0.25 | 0.49 | 1.01 |
| Gross Margin | 36.2% | 36.2% | 39.0% | 46.0% | 49.4% |
| Operating Margin | -0.9% | -0.9% | -14.2% | 16.2% | 23.6% |
| Net Margin | -5.8% | -5.8% | -12.2% | 13.0% | 22.4% |
| Balance Sheet | |||||
| Debt/Equity | 0.01 | 0.01 | 0.00 | 0.01 | 0.04 |
| Current Ratio | 6.90 | 6.90 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-29.7M | $-29.7M | $-71.4M | $-24.2M | $-12.5M |
| Returns | |||||
| ROE | -1.4% | -1.4% | -2.4% | 4.0% | 22.6% |
| Valuation | |||||
| P/E | — | — | — | 95.86 | — |
| EV/EBITDA | — | — | — | 57.34 | — |
| P/B | 2.47 | 2.47 | 2.55 | 3.80 | — |
| Growth & Yield | |||||
| Revenue Growth | 16.6% | 16.6% | -38.0% | -0.4% | — |
| EPS Growth | 44.0% | 44.0% | -151.0% | -51.5% | — |
| Dividend Yield | 0.7% | 0.7% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-10.7%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.25 → -0.14
Residual
-11.4%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.